Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Enrollment starts in phase IIa study of tegavivint in desmoid tumors

July 29, 2020

Dihydroorotate dehydrogenase inhibitors discovered at Janssen

July 29, 2020

EBV drives gastric cancer by rewiring host epigenomes

July 29, 2020

HS-201 studied in phase I for imaging of solid tumors

July 28, 2020

Praxis Biotech discloses new FAPalpha inhibitors

July 28, 2020

Genentech discovers Ire1-alpha inhibitors

July 27, 2020

Biomea Fusion discovers menin (MEN1)/MLL interaction inhibitors

July 27, 2020

JAK1 inhibitor CJ-14939 may be a potential adjuvant for NSCLC patients with erlotinib resistance

July 27, 2020

HMPL-306 enters phase I study for hematological malignancies in China

July 27, 2020

Cybrexa Therapeutics details development of peptide-drug conjugate CBX-13 for solid tumors

July 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...